» Articles » PMID: 29137274

Effective Protection Against Acute Respiratory Distress Syndrome/sepsis Injury by Combined Adipose-derived Mesenchymal Stem Cells and Preactivated Disaggregated Platelets

Overview
Journal Oncotarget
Specialty Oncology
Date 2017 Nov 16
PMID 29137274
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

This study assessed whether combining adipose-derived mesenchymal stem cells (ADMSC) with preactivated, disaggregated shape-changed platelets (PreD-SCP) was superior to either therapy alone for protecting rat lung from acute respiratory distress syndrome (ARDS) complicated by sepsis. ARDS and sepsis were induced through 100% oxygen inhalation and peritoneal administration of 1.5 mg/kg lipopolysaccharide (LPS), respectively. Adult-male Sprague-Dawley rats (n=40) were randomized into sham-control (SC), ARDS-LPS, ARDS-LPS-ADMSC (1.2x10 cells), ARDS-LPS-PreD-SCP (3.0x10, intravenous administration), and ARDS-LPS-ADMS/PreD-SCP groups, and were sacrificed 72 h after 48 h ARDS induction. Lung injury scores (LIS) and collagen deposition were highest in ARDS-LPS, lowest in SC, higher in ARDS-LPS+ADMSC than in ARDS-LPS+PreD-SCP and ARDS-LPS+ADMS/PreD-SCP, and higher in ARDS-LPS+PreD-SCP than in ARDS-LPS+ADMS/PreD-SCP (all p<0.0001). Alveolar-sac numbers, oxygen saturation, endothelial marker levels, and mitochondrial cytochrome-C levels exhibited opposite patterns with respect to LIS (all p<0.001). Levels of inflammatory, oxidative-stress, apoptosis, mitochondrial/DNA damage, and MAPK and Akt signaling markers exhibited patterns identical to that of LIS (all p<0.001). Anti-oxidant and anti-inflammatory protein levels increased progressively from SC to ARDS-LPS+ADMS/PreD-SCP (all p<0.0001). These findings indicate combined ADMSC/PreD-SCP was superior to either therapy alone for protecting rat lung from ARDS-sepsis injury.

Citing Articles

Outcomes of combined mitochondria and mesenchymal stem cells-derived exosome therapy in rat acute respiratory distress syndrome and sepsis.

Lin K, Fang W, Yeh J, Chiang J, Chiang H, Shao P World J Stem Cells. 2024; 16(6):690-707.

PMID: 38948095 PMC: 11212548. DOI: 10.4252/wjsc.v16.i6.690.


Synergic effect of combined xenogeneic mesenchymal stem cells and ceftriaxone on acute septic arthritis.

Sung P, Yin T, Chiang J, Chen C, Huang C, Lee M Stem Cells Transl Med. 2024; 13(8):724-737.

PMID: 38894649 PMC: 11328939. DOI: 10.1093/stcltm/szae034.


Functional enhancement strategies to potentiate the therapeutic properties of mesenchymal stromal cells for respiratory diseases.

Lopes-Pacheco M, Rocco P Front Pharmacol. 2023; 14:1067422.

PMID: 37007034 PMC: 10062457. DOI: 10.3389/fphar.2023.1067422.


Prognostic value of neutrophils to lymphocytes and platelets ratio for 28-day mortality in patients with acute respiratory distress syndrome: a retrospective study.

Nie S, Wang H, Liu Q, Tang Z, Tao W, Wang N BMC Pulm Med. 2022; 22(1):314.

PMID: 35971101 PMC: 9376578. DOI: 10.1186/s12890-022-02112-w.


Mesenchymal stem cells: a new front emerges in coronavirus disease 2019 treatment.

Raza S, Khan M Cytotherapy. 2022; 24(8):755-766.

PMID: 35880307 PMC: 7362822. DOI: 10.1016/j.jcyt.2020.07.002.


References
1.
Wu C, Chen W, Zao B, Lai P, Lin T, Lo H . Regenerative potentials of platelet-rich plasma enhanced by collagen in retrieving pro-inflammatory cytokine-inhibited chondrogenesis. Biomaterials. 2011; 32(25):5847-54. DOI: 10.1016/j.biomaterials.2011.05.002. View

2.
Chawla R, Mansuriya J, Modi N, Pandey A, Juneja D, Chawla A . Acute respiratory distress syndrome: Predictors of noninvasive ventilation failure and intensive care unit mortality in clinical practice. J Crit Care. 2015; 31(1):26-30. DOI: 10.1016/j.jcrc.2015.10.018. View

3.
Kim H, Yeom J, Koh Y, Yeo J, Kang K, Kang Y . Anti-inflammatory effect of platelet-rich plasma on nucleus pulposus cells with response of TNF-α and IL-1. J Orthop Res. 2013; 32(4):551-6. DOI: 10.1002/jor.22532. View

4.
Ware L, Matthay M . The acute respiratory distress syndrome. N Engl J Med. 2000; 342(18):1334-49. DOI: 10.1056/NEJM200005043421806. View

5.
Bhargava M, Wendt C . Biomarkers in acute lung injury. Transl Res. 2012; 159(4):205-17. PMC: 4537856. DOI: 10.1016/j.trsl.2012.01.007. View